JMS Co

JMS Co Liabilities

The The Liabilities of JMS Co (7702.T) as of Nov 3, 2026 is 41.27 B JPY. In the previous year, The Liabilities was 40.50 B JPY — a change of 1.90% (higher).

Liabilities

41.27 BJPY

YoY

1.90%

Last updated:

In 2026, JMS Co's total liabilities amounted to 41.27 B JPY, a 1.90% difference from the 40.50 B JPY total liabilities in the previous year.

The JMS Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2019
35.42 B JPY
Jan 1, 2020
34.09 B JPY
Jan 1, 2021
34.09 B JPY
Jan 1, 2022
34.87 B JPY
Jan 1, 2023
35.70 B JPY
Jan 1, 2024
43.96 B JPY
Jan 1, 2025
40.50 B JPY
Jan 1, 2026
41.27 B JPY
The JMS Co Liabilities history
YEARLiabilitiesYoY
41.27 BJPY+1.90%
40.50 BJPY-7.86%
43.96 BJPY+23.12%
35.70 BJPY+2.38%
34.87 BJPY+2.31%
34.09 BJPY-0.01%
34.09 BJPY-3.74%
35.42 BJPY-0.93%
35.75 BJPY+3.27%
34.62 BJPY+1.02%
34.27 BJPY+18.48%
28.92 BJPY+27.96%
22.60 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing JMS Co's Liabilities

JMS Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating JMS Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing JMS Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

JMS Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in JMS Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about JMS Co stock

The Liabilities of JMS Co is 41.27 B JPY in 2026.

The Liabilities of JMS Co changed from 40.50 B JPY to 41.27 B JPY, representing a 1.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities JMS Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's JMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — JMS Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — JMS Co